Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

VivoSim Labs, Inc. Operating Cash Flow

VivoSim Labs, Inc. (VIVS) reported Operating Cash Flow of -$3.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12

  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.21M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.24M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.27M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.38M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for fiscal 2026 was -$10.83M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$9.46M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$14.65M.
  • VivoSim Labs, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$12.41M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 21 monthNet Cash Provided by (Used in) Operating Activities 24 monthNet Cash Provided by (Used in) Operating Activities 59 monthNet Cash Provided by (Used in) Operating Activities 62 monthNet Cash Provided by (Used in) Operating Activities 65 monthNet Cash Provided by (Used in) Operating Activities 68 monthNet Cash Provided by (Used in) Operating Activities 71 monthNet Cash Provided by (Used in) Operating Activities 74 monthNet Cash Provided by (Used in) Operating Activities 77 monthNet Cash Provided by (Used in) Operating Activities 80 month
2026-06-30-$3.21M
10-Q · filed 2026-08-12
-$5.45M
derived: sum of 2 quarters · filed 2026-08-12
-$7.72M
derived: sum of 3 quarters · filed 2026-08-12
-$10.10M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14
-$4.51M
derived: sum of 2 quarters · filed 2026-07-14
-$6.89M
derived: sum of 3 quarters · filed 2026-07-14
-$10.83M
10-K · filed 2026-07-14
2025-12-31-$2.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11
-$4.65M
derived: sum of 2 quarters · filed 2026-02-11
-$8.59M
10-Q · filed 2026-02-11
-$10.62M
derived: sum of 4 quarters · filed 2026-08-12
2025-09-30-$2.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
-$6.32M
10-Q · filed 2025-11-06
-$8.35M
derived: sum of 3 quarters · filed 2026-08-12
-$10.15M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$3.94M
10-Q · filed 2026-08-12
-$5.97M
derived: sum of 2 quarters · filed 2026-08-12
-$7.78M
derived: sum of 3 quarters · filed 2026-08-12
-$10.42M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$2.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14
-$3.84M
derived: sum of 2 quarters · filed 2026-07-14
-$6.48M
derived: sum of 3 quarters · filed 2026-07-14
-$9.46M
10-K · filed 2026-07-14
2024-12-31-$1.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11
-$4.44M
derived: sum of 2 quarters · filed 2026-02-11
-$7.43M
10-Q · filed 2026-02-11
-$10.10M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30-$2.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
-$5.63M
10-Q · filed 2025-11-06
-$8.30M
derived: sum of 3 quarters · filed 2025-11-06
-$11.82M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$2.98M
10-Q · filed 2025-08-12
-$5.65M
derived: sum of 2 quarters · filed 2025-08-12
-$9.18M
derived: sum of 3 quarters · filed 2025-08-12
-$12.32M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05
-$6.19M
derived: sum of 2 quarters · filed 2025-06-05
-$9.34M
derived: sum of 3 quarters · filed 2025-06-05
-$14.65M
10-K · filed 2025-06-05
2023-12-31-$3.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-19
-$6.67M
derived: sum of 2 quarters · filed 2025-02-19
-$11.98M
10-Q · filed 2025-02-19
-$16.71M
derived: sum of 4 quarters · filed 2025-02-19
2023-09-30-$3.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08
-$8.46M
10-Q · filed 2024-11-08
-$13.19M
derived: sum of 3 quarters · filed 2024-11-08
-$16.24M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$5.31M
10-Q · filed 2024-08-05
-$10.04M
derived: sum of 2 quarters · filed 2024-08-05
-$13.09M
derived: sum of 3 quarters · filed 2024-08-05
-$15.30M
derived: sum of 4 quarters · filed 2024-08-05
2023-03-31-$4.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31
-$7.78M
derived: sum of 2 quarters · filed 2024-05-31
-$9.99M
derived: sum of 3 quarters · filed 2024-05-31
-$12.41M
10-K · filed 2024-05-31
2022-12-31-$3.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
-$5.26M
derived: sum of 2 quarters · filed 2024-02-08
-$7.67M
10-Q · filed 2024-02-08
-$9.22M
derived: sum of 4 quarters · filed 2024-02-08
2022-09-30-$2.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-09
-$4.63M
10-Q · filed 2023-11-09
-$6.17M
derived: sum of 3 quarters · filed 2023-11-09
-$9.53M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$2.41M
10-Q · filed 2023-08-10
-$3.96M
derived: sum of 2 quarters · filed 2023-08-10
-$7.31M
derived: sum of 3 quarters · filed 2023-08-10
-$9.45M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$1.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14
-$4.90M
derived: sum of 2 quarters · filed 2023-07-14
-$7.04M
derived: sum of 3 quarters · filed 2023-07-14
-$8.45M
10-K · filed 2023-07-14
2021-12-31-$3.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09
-$5.50M
derived: sum of 2 quarters · filed 2023-02-09
-$6.91M
10-Q · filed 2023-02-09
-$9.03M
derived: sum of 4 quarters · filed 2023-02-09
2021-09-30-$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10
-$3.56M
10-Q · filed 2022-11-10
-$5.67M
derived: sum of 3 quarters · filed 2022-11-10
-$7.16M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$1.41M
10-Q · filed 2022-08-11
-$3.53M
derived: sum of 2 quarters · filed 2022-08-11
-$5.02M
derived: sum of 3 quarters · filed 2022-08-11
-$12.17M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10
-$3.60M
derived: sum of 2 quarters · filed 2022-06-10
-$10.75M
derived: sum of 3 quarters · filed 2022-06-10
-$13.32M
10-K · filed 2022-06-10
2020-12-31-$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14
-$8.64M
derived: sum of 2 quarters · filed 2022-02-14
-$11.21M
10-Q · filed 2022-02-14
-$14.42M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30-$7.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08
-$9.72M
10-Q · filed 2021-11-08
-$12.93M
derived: sum of 3 quarters · filed 2021-11-08
-$13.51M
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30-$2.57M
10-Q · filed 2021-08-06
-$5.78M
derived: sum of 2 quarters · filed 2021-08-06
-$6.36M
derived: sum of 3 quarters · filed 2021-08-06
-$11.52M
derived: sum of 4 quarters · filed 2021-08-06
2020-03-31-$3.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15
-$3.79M
derived: sum of 2 quarters · filed 2021-06-15
-$8.95M
derived: sum of 3 quarters · filed 2021-06-15
-$14.88M
10-K · filed 2021-06-15
2019-12-31-$583.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08
-$5.74M
derived: sum of 2 quarters · filed 2021-02-08
-$11.67M
10-Q · filed 2021-02-08
-$16.75M
derived: sum of 4 quarters · filed 2021-02-08
2019-09-30-$5.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05
-$11.09M
10-Q · filed 2020-11-05
-$16.17M
derived: sum of 3 quarters · filed 2020-11-05
-$20.12M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$5.93M
10-Q · filed 2020-08-10
-$11.01M
derived: sum of 2 quarters · filed 2020-08-10
-$14.96M
derived: sum of 3 quarters · filed 2020-08-10
-$19.29M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$5.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28
-$9.03M
derived: sum of 2 quarters · filed 2020-05-28
-$13.35M
derived: sum of 3 quarters · filed 2020-05-28
-$20.38M
10-K · filed 2020-05-28
2018-12-31-$3.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10
-$8.28M
derived: sum of 2 quarters · filed 2020-02-10
-$15.30M
10-Q · filed 2020-02-10
-$20.91M
derived: sum of 4 quarters · filed 2020-02-10
2018-09-30-$4.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07
-$11.35M
10-Q · filed 2019-11-07
-$16.96M
derived: sum of 3 quarters · filed 2019-11-07
-$23.40M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$7.02M
10-Q · filed 2019-08-08
-$12.63M
derived: sum of 2 quarters · filed 2019-08-08
-$19.08M
derived: sum of 3 quarters · filed 2019-08-08
-$25.23M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$5.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03
-$12.05M
derived: sum of 2 quarters · filed 2019-06-03
-$18.20M
derived: sum of 3 quarters · filed 2019-06-03
-$28.86M
10-K · filed 2019-06-03
2017-12-31-$6.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07
-$12.59M
derived: sum of 2 quarters · filed 2019-02-07
-$23.25M
10-Q · filed 2019-02-07
2017-09-30-$6.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08
-$16.80M
10-Q · filed 2018-11-08
2017-06-30-$10.65M
10-Q · filed 2018-08-09
2014-09-30$6.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07
$9.70M
10-Q · filed 2014-11-07
$4.30M
derived: sum of 3 quarters · filed 2014-11-07
$395.00K
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$3.40M
10-Q · filed 2014-08-08
-$2.00M
derived: sum of 2 quarters · filed 2014-08-08
-$5.91M
derived: sum of 3 quarters · filed 2014-08-08
-$9.50M
derived: sum of 4 quarters · filed 2014-08-08
2014-03-31-$5.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10
-$9.30M
derived: sum of 2 quarters · filed 2014-06-10
-$12.90M
derived: sum of 3 quarters · filed 2014-06-10
-$15.56M
10-K · filed 2014-06-10
2013-12-31-$3.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06
-$7.50M
derived: sum of 2 quarters · filed 2014-02-06
-$10.16M
10-Q · filed 2014-02-06
-$12.92M
derived: sum of 4 quarters · filed 2014-02-06
-$25.94M
10-Q · filed 2014-02-06
2013-09-30-$3.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08
-$6.26M
10-Q · filed 2013-11-08
-$9.01M
derived: sum of 3 quarters · filed 2013-11-08
-$10.99M
derived: sum of 4 quarters · filed 2014-02-06
-$22.03M
10-Q · filed 2013-11-08
2013-06-30-$2.66M
10-Q · filed 2013-08-09
-$5.42M
derived: sum of 2 quarters · filed 2013-08-09
-$7.40M
derived: sum of 3 quarters · filed 2014-02-06
-$9.69M
derived: sum of 4 quarters · filed 2014-02-06
-$18.44M
10-Q · filed 2013-08-09
2013-03-31-$2.75M
10-KT · filed 2013-05-24
-$4.73M
derived: sum of 2 quarters · filed 2014-02-06
-$7.03M
derived: sum of 3 quarters · filed 2014-02-06
-$8.89M
derived: sum of 4 quarters · filed 2014-02-06
-$15.78M
10-KT · filed 2013-05-24
2012-12-31-$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06
-$4.28M
derived: sum of 2 quarters · filed 2014-02-06
-$6.14M
10-Q · filed 2014-02-06
-$9.69M
10-KT · filed 2013-05-24
-$13.02M
10-K · filed 2013-03-15
2012-09-30-$2.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08
-$4.16M
10-Q · filed 2013-11-08
-$7.71M
10-Q · filed 2012-11-14
-$7.72M
derived: sum of 4 quarters · filed 2013-11-08
-$11.04M
10-Q · filed 2012-11-14
2012-06-30-$1.86M
10-Q · filed 2013-08-09
-$5.41M
10-Q · filed 2012-08-14
-$5.43M
derived: sum of 3 quarters · filed 2013-08-09
-$5.43M
derived: sum of 4 quarters · filed 2013-08-09
-$8.74M
10-Q · filed 2012-08-14
2012-03-31-$3.56M
10-KT · filed 2013-05-24
-$3.56M
10-Q · filed 2012-05-15
-$3.57M
derived: sum of 2 quarters · filed 2013-05-24
-$3.57M
derived: sum of 3 quarters · filed 2013-05-24
-$3.86M
derived: sum of 4 quarters · filed 2013-05-24
-$6.89M
10-Q · filed 2012-05-15
2011-12-31-$9.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17
-$10.52K
10-Q · filed 2012-01-17
-$308.10K
derived: sum of 3 quarters · filed 2012-08-14
-$1.91M
10-KT · filed 2013-05-24
-$149.67K
10-Q · filed 2012-01-17
2011-09-30-$647.00
10-Q · filed 2011-10-31
-$298.22K
derived: sum of 2 quarters · filed 2012-08-14
-$959.07K
10-Q · filed 2012-11-14
-$636.46K
derived: sum of 4 quarters · filed 2012-08-14
-$139.80K
10-Q · filed 2011-10-31
2011-06-30-$297.57K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
-$609.34K
10-Q · filed 2012-08-14
-$635.81K
derived: sum of 3 quarters · filed 2012-08-14
-$658.03K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31-$311.77K
10-Q · filed 2012-05-15
-$338.24K
derived: sum of 2 quarters · filed 2012-05-15
-$360.46K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31-$26.47K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17
-$48.69K
10-Q · filed 2012-01-17
-$820.00K
10-KT · filed 2013-05-24
2010-09-30-$22.23K
10-Q · filed 2011-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70